Zenas BioPharma (ZBIO) EBITDA (2023 - 2026)
Zenas BioPharma (ZBIO) posted quarterly EBITDA of -$77.4 million for Q1 2026, down 107.21% year-over-year from $1.1 billion in Q1 2025, and up 67.5% quarter-over-quarter from -$238.0 million in Q4 2025.
Zenas BioPharma (ZBIO) EBITDA (2023 - 2026) Analysis & Trends
Zenas BioPharma's EBITDA history runs 4 years deep, the most recent figure standing at -$77.4 million for Q1 2026.
- In Q1 2026, EBITDA fell 107.21% year-over-year to -$77.4 million; the TTM figure through Mar 2026 stood at -$423.1 million (down 143.65% YoY), while the FY2025 annual figure was -$383.1 million, down 133.73% from the prior year.
- EBITDA for Q1 2026 stood at -$77.4 million, up from -$238.0 million in the prior quarter.
- The five-year high for EBITDA was $35.6 million in Q3 2023, with the low at -$238.0 million in Q4 2025.
- The 4-year median for EBITDA is -$41.0 million (2024), against an average of -$55.8 million.
- Peak annual rise in EBITDA reached 28.29% in 2025, while the deepest fall reached 327.85% in 2025.
- Zenas BioPharma's EBITDA stood at -$24.8 million in 2023, then plunged by 124.48% to -$55.6 million in 2024, then tumbled by 327.85% to -$238.0 million in 2025, then soared by 67.5% to -$77.4 million in 2026.
- Business Quant data shows ZBIO's EBITDA at -$77.4 million in Q1 2026, -$238.0 million in Q4 2025, and -$52.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Zenas BioPharma | 1.87 Bn | 748.44 Mn | - | -107.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -107.66 Mn |
| Mar 31, 2026 | -77.35 Mn |
| Dec 31, 2025 | -237.98 Mn |
| Sep 30, 2025 | -52.58 Mn |
| Jun 30, 2025 | -55.16 Mn |
| Mar 31, 2025 | -37.33 Mn |
| Dec 31, 2024 | -55.62 Mn |
| Sep 30, 2024 | -40.98 Mn |
| Jun 30, 2024 | -39.70 Mn |
| Mar 31, 2024 | -27.58 Mn |
| Dec 31, 2023 | -24.78 Mn |
| Sep 30, 2023 | 35.62 Mn |